September 26, 2020

The Niche

Knoepfler lab stem cell blog

Search Results for: training

2 min read

The California Stem Cell Agency CIRM seems to be in budget cutting mode these days, which from a general perspective makes sense as CIRM seeks to continue operating on its remaining funding through a longer period of time as far out as to 2020. However, not all cuts are necessarily positive. For example, CIRM reportedly (note: many within the California stem cell community overall are concerned about this possibility) might be considering ending its fantastically successful Bridges training program. That would be very counterproductive. In fact, the …Read More

2 min read

Last week I went to the lab safety training that is required on an annual basis. I believe I’ve gone to it about a half-dozen times now and I know certain parts by heart. However this time there was something brand new. Active shooter training. I have to admit that caught my attention. What is active shooter training? It is supposed to be prepping you for what to do if there is an gunman actively going around one’s workplace shooting and killing people. Scary, …Read More

2 min read

With all the excitement over the potential of stem cells to transform medicine, a key bottleneck is physician training. Just how many doctors in the entire US have years of real experience and training in clinical use of stem cells….hmmm, let’s see….I can only think of a few in the whole country. Yes, it’s really that bad. I proposed recently that academic centers and hospitals establish formal, 1-year fellowship programs for physicians. The curriculum of that training program is detailed at right. Unfortunately, most …Read More

2 min read

One of the problems in the stem cell field is that so few doctors have adequate training in stem cells (biology, transplantation, regulatory issues, GMP, ethics, patient rights, etc) and yet they are treating loads of patients in a for-profit setting. This not puts patients at great risk, but also the physicians themselves are putting themselves at risk both in terms of punitive regulatory actions and patient litigation. More broadly the untrained practice of stem cell-based medicine puts the stem cell field at risk. I …Read More